Skip to content

Insider · CIK 0001953107

Enavate Sciences GP, LLC

owner

Files at CAMP (Camp4 Therapeutics Corp). First filing Oct 17, 2024, latest Oct 17, 2024.

Enavate Sciences GP, LLC files SEC Form 4 as 10% owner at CAMP (Camp4 Therapeutics Corp). Since Oct 17, 2024, Enavate Sciences GP, LLC has reported 1 open-market buy worth $15M and 0 open-market sells worth $0, the latest filed on Oct 17, 2024.

A track record needs three past buys with six months of prices behind them; Enavate Sciences GP, LLC has 0, so none is measured yet.

The newest scored trade: bought $15M of CAMP on Oct 15, 2024, filed Oct 17, 2024, scored 57 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$15M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CAMP: Camp4 Therapeutics Corp

CAMPOct 9, 2026 · close 3.77

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
57Moderate
CAMPbuy 7
Camp4 Therapeutics Corp
$15M
1,363,636 shares
+56%+10% from low0% from high

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Common Stockindirect: By Everest Aggregator, LP
+2,422,166--2,422,166Oct 17, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
POpen-market purchase
Common Stockindirect: By Everest Aggregator, LP
+1,363,636$11.00$15M3,785,802Oct 17, 2024
Oct 15, 2024CAMP
Camp4 Therapeutics Corp
CConversion
Series B Preferred Stockderivativeindirect: By Everest Aggregator, LP
-27,166,530--0Oct 17, 2024

Questions about Enavate Sciences GP, LLC

Answered from the filings on this page, as of the latest one.

Is Enavate Sciences GP, LLC buying or selling?

Not in the last 12 months. Enavate Sciences GP, LLC's latest open-market trade on SEC Form 4 was bought $15M of CAMP on Oct 15, 2024.

How did Enavate Sciences GP, LLC's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Enavate Sciences GP, LLC has 0.

Where does Enavate Sciences GP, LLC file Form 4?

Enavate Sciences GP, LLC has filed Form 4 at CAMP (Camp4 Therapeutics Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.